A multicenter analysis of prognostic factors in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib.

被引：0
|
作者：
Smith, Alan D.
Chan, Kelvin K.
Lim, Howard John
Cheung, Winson Y.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[2] Princess Margaret Hosp, Sunnybrook Odette Canc Ctr, Toronto, ON M4X 1K9, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14532
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prospective evaluation of the factors predicting the prognosis of advanced hepatocellular carcinoma (HCC) patients treated with sorafenib.
    Adachi, Takuya
    Nouso, Kazuhiro
    Miyahara, Koji
    Dohi, Chihiro
    Wada, Nozomu
    Takeuchi, Yasuto
    Kuwaki, Kenji
    Onishi, Hideki
    Ikeda, Fusao
    Nakamura, Shinichiro
    Shiraha, Hidenori
    Takaguchi, Koichi
    Uematsu, Shuji
    Iwadou, Shouta
    Takuma, Yoshitaka
    Hagihara, Hiroaki
    Takabatake, Hiroyuki
    Takaki, Akinobu
    Okada, Hiroyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] A population-based analysis of prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib. Journal
    Smith, Alan D.
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [3] Prognostic factors in patients with advanced hepatocellular carcinoma treated with sorafenib
    Pinter, M.
    Sieghart, W.
    Hucke, F.
    Graziadei, I.
    Vogel, W.
    Maieron, A.
    Koenigsberg, R.
    Weissmann, A.
    Kornek, G.
    Matejka, J.
    Stauber, R.
    Buder, R.
    Gruenberger, B.
    Schoeniger-Hekele, M.
    Mueller, C.
    Peck-Radosavljevic, M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 949 - 959
  • [4] A comparison of prognostic systems in hepatocellular carcinoma treated with sorafenib.
    Bagnall, Elizabeth Marie
    Gresham, Gillian
    Czaykowski, Piotr
    Chan, Kelvin K.
    Fung, Jennifer
    Cuvelier, Susan
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Baseline neutrophil-to-lymphocyte ratio (NLR) and early toxicity as prognostic factors in advanced hepatocellular carcinoma patients treated with sorafenib.
    Bruixola, Gema
    Mauricio Nino, Oscar
    Diaz-Beveridge, Robert
    Reche, Encarnacion
    Salvador, Carmen
    Escoin, Corina
    Akhoundova, Dilara
    Segura, Angel
    Gimenez, Alejandra
    Aparicio, Jorge
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] KEYNOTE-224: Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
    Zhu, Andrew X.
    Finn, Richard S.
    Cattan, Stephane
    Edeline, Julien
    Ogasawara, Sadahisa
    Palmer, Daniel H.
    Verslype, Chris
    Zagonel, Vittorina
    Rosmorduc, Olivier
    Vogel, Arndt
    Sarker, Debashis
    Verset, Gontran
    Chan, Stephen Lam
    Knox, Jennifer J.
    Daniele, Bruno
    Ebbinghaus, Scot
    Ma, Junshui
    Siegel, Abby B.
    Cheng, Ann-Lii
    Kudo, Masatoshi
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [7] Impact of HCV treatment in patients with advanced hepatocellular carcinoma on sorafenib.
    Herman, Michael
    Zhang, Yuhua
    Wang, Lisa
    Sim, Hao-Wen
    Knox, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Sorafenib in advanced hepatocellular carcinoma (HCC) : Ascites as prognostic factor
    Koch, S.
    Niederle, I.
    Gamstaetter, T.
    Schuchmann, M.
    Galle, P.
    Woerns, M.
    Weinmann, A.
    INTERNIST, 2013, 54 (06): : 745 - 745
  • [9] Sorafenib in advanced hepatocellular carcinoma (HCC) : Ascites as prognostic factor
    Koch, S.
    Niederle, I.
    Gamstaetter, T.
    Schuchmann, M.
    Galle, P.
    Woerns, M.
    Weinmann, A.
    INTERNIST, 2013, 54 : 10 - 10
  • [10] PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB
    Sacco, R.
    Ciruolo, M.
    Paolillo, R.
    Ramai, D.
    Tortora, R.
    Di Costanzo, G. G.
    Burlone, M. E.
    Pirisi, M.
    Federico, P.
    Daniele, B.
    Silletta, M.
    Gallo, P.
    Cocuzza, C.
    Russello, M.
    Cabibbo, G.
    Cesario, S.
    Masi, G.
    Marzi, L.
    Mega, A.
    Granito, A.
    Pieri, G.
    Giannini, E.
    Gadaleta-Caldarola, G.
    Dadduzio, V
    Giordano, G.
    Giacomelli, L.
    Papa, S.
    Renzulli, M.
    Maida, M.
    Ghidini, M.
    Facciorusso, A.
    DIGESTIVE AND LIVER DISEASE, 2023, 55 : S119 - S120
12345